Cargando…
Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes—A randomized placebo‐controlled crossover trial
The use of the sleep‐promoting hormone melatonin is rapidly increasing as an assumed safe sleep aid. During the last decade, accumulating observations suggest that melatonin affects glucose homeostasis, but the precise role remains to be defined. We investigated the metabolic effects of long‐term me...
Autores principales: | Lauritzen, Esben S., Kampmann, Ulla, Pedersen, Mette G. B., Christensen, Lise‐Lotte, Jessen, Niels, Møller, Niels, Støy, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9540532/ https://www.ncbi.nlm.nih.gov/pubmed/35619221 http://dx.doi.org/10.1111/jpi.12809 |
Ejemplares similares
-
GLUT4 and UBC9 Protein Expression Is Reduced in Muscle from Type 2 Diabetic Patients with Severe Insulin Resistance
por: Kampmann, Ulla, et al.
Publicado: (2011) -
Reduced CD300LG mRNA tissue expression, increased intramyocellular lipid content and impaired glucose metabolism in healthy male carriers of Arg82Cys in CD300LG: a novel genometabolic cross-link between CD300LG and common metabolic phenotypes
por: Støy, Julie, et al.
Publicado: (2015) -
Parity and type 2 diabetes mellitus: a study of insulin resistance and β-cell function in women with multiple pregnancies
por: Iversen, Ditte Smed, et al.
Publicado: (2016) -
Effects of Renal Denervation on Insulin Sensitivity and Inflammatory Markers in Nondiabetic Patients with Treatment-Resistant Hypertension
por: Kampmann, Ulla, et al.
Publicado: (2017) -
Altered gene expression and repressed markers of autophagy in skeletal muscle of insulin resistant patients with type 2 diabetes
por: Møller, Andreas Buch, et al.
Publicado: (2017)